People with schizophrenia often show deficits in neurocognitive and social cognitive abilities. Neurocognitive abilities include processing speed, attention/vigilance, reasoning/problem solving,…
Read More
An important study led by BBRF grantees has closely examined a commonplace pharmacologic property of many antipsychotic and other medications commonly prescribed to people with chronic schizophrenia…
Read More
From BBRF's Brain & Behavior Magazine - July 2019 Issue
Progress in research usually doesn’t follow a straight-line path. But if you chart the advances in schizophrenia research made by Gregory A…
Read More
In a Comparison of Two Kinds of Cognitive Training, One Appeared to Help Schizophrenia Patients More
A study just published in the American Journal of Psychiatry compares the two dominant approaches for treating cognitive deficits in people with schizophrenia, symptoms of the illness not addressed…
Read More
Adding the drug guanfacine to a proven therapy program to treat cognitive deficits led to even better results for individuals with schizotypal personality disorder, say researchers who have just…
Read More
